Aldecoa, Cesar
Llau, Juan V.
Nuvials, Xavier
Artigas, Antonio
Funding for this research was provided by:
Grifols (N/A)
Article History
Received: 17 January 2020
Accepted: 5 June 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Cesar Aldecoa has received payment for lectures and travel expenses from Fresenius, and Octapharma. Juan V Llau has received payment for lectures or participation in educational activities, or travel expenses from Cardinal, CSL-Behring, LFB, Octapharma, Rovi, Sanofi, and Vifor Pharma. Xavier Nuvials has received payment for lectures, and travel expenses from Astellas, Gilead, MSD, and Pfizer. Antonio Artigas has received research grants from Fisher & Paykel, Grifols, and Hill-Rom; has participated in scientific advisory boards for Global Sepsis Alliance, Grifols, and Lilly Foundation; has received payment for lectures or participation in educational activities from Astute, Edwards, and Grifols.